Keensight to acquire medtech firm Isto Biologics from Thompson Street

TSCP will retain a minority stake in Isto Biologics.

17 September 2025•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Deals North America US Healthcare Briefs